ProAxsis Ltd - Product Pipeline Analysis, 2024 Update

ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd,, is a medical equipment manufacturer company that develops and supplies diagnostic devices. It focuses on respiratory biomarkers, for the patients suffering from chronic respiratory diseases. ProAxsis products include ProteaseTag active neutrophil elastase immunoassay, NEATstik, ProteaseTag active proteinase 3 immunoassay and K-Postn immunoassay. The company offers products for the treatment of diseases associated with breathlessness, persistent cough and chronic lung function decline, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), bronchiectasis and alpha-1 anti-trypsin deficiency (A1ATD). Its services include clinical trial support and research and development projects. It is a subsidiary of NetScientific UK Ltd. ProAxsis is headquartered in Belfast, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company ProAxsis Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

ProAxsis Ltd Company Overview
ProAxsis Ltd Company Snapshot
ProAxsis Ltd Pipeline Products and Ongoing Clinical Trials Overview
ProAxsis Ltd - Pipeline Analysis Overview
ProAxsis Ltd - Key Facts
ProAxsis Ltd - Major Products and Services
ProAxsis Ltd Pipeline Products by Development Stage
ProAxsis Ltd Pipeline Products Overview
2-Plex Protease Multiplex Panel
2-Plex Protease Multiplex Panel Product Overview
Cathepsin K-Dependent Periostin Cleavage Biomarker Assay - Bone Fragility
Cathepsin K-Dependent Periostin Cleavage Biomarker Assay - Bone Fragility Product Overview
K-POSTN Assay
K-POSTN Assay Product Overview
NE Premium Assay
NE Premium Assay Product Overview
ProteaseTag - COPD
ProteaseTag - COPD Product Overview
ProteaseTag - Cystic Fibrosis
ProteaseTag - Cystic Fibrosis Product Overview
ProteaseTag Active Immuno Assay - Chronic Human Diseases
ProteaseTag Active Immuno Assay - Chronic Human Diseases Product Overview
ProteaseTag Active Immunoassay - Pancreatic Elastase
ProteaseTag Active Immunoassay - Pancreatic Elastase Product Overview
ProteaseTag Active Immunoassay - Tryptase
ProteaseTag Active Immunoassay - Tryptase Product Overview
Remote Respiratory Monitoring Tool
Remote Respiratory Monitoring Tool Product Overview
SARS-CoV-2 Serology ELISA
SARS-CoV-2 Serology ELISA Product Overview
ProAxsis Ltd - Key Competitors
ProAxsis Ltd - Key Employees
ProAxsis Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ProAxsis Ltd, Recent Developments
May 09, 2024: Proaxsis Awarded Innovate UK Grant to Expedite Point of Care Range in Respiratory Diagnostics
Jul 26, 2022: ProAxsis announces additional key appointments
May 16, 2022: ProAxsis announces "impressive" results in performance evaluation of the in-licensed AstraZeneca COVID-19 antibody test
Jan 19, 2022: ProAxsis expands inflammatory biomarker research via new partnership with Queen’s University Belfast
Jan 10, 2022: NetScientific: ProAxsis CEO end of year update
Oct 22, 2021: ProAxsis announces the approval of a key US patent
Oct 13, 2021: ProAxsis expands COVID-19 research programme with new award
Sep 03, 2021: ProAxsis presents exciting new data at the ERS International Congress 2021
Jun 07, 2021: ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
Dec 10, 2020: ProAxsis awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients
Appendix
Methodology
About the Analyst
Contact the Publisher
Disclaimer

List of Tables

ProAxsis Ltd Pipeline Products and Ongoing Clinical Trials Overview
ProAxsis Ltd Pipeline Products by Equipment Type
ProAxsis Ltd Pipeline Products by Indication
ProAxsis Ltd, Key Facts
ProAxsis Ltd, Major Products and Services
ProAxsis Ltd Number of Pipeline Products by Development Stage
ProAxsis Ltd Pipeline Products Summary by Development Stage
2-Plex Protease Multiplex Panel - Product Status
2-Plex Protease Multiplex Panel - Product Description
Cathepsin K-Dependent Periostin Cleavage Biomarker Assay - Bone Fragility - Product Status
Cathepsin K-Dependent Periostin Cleavage Biomarker Assay - Bone Fragility - Product Description
K-POSTN Assay - Product Status
K-POSTN Assay - Product Description
NE Premium Assay - Product Status
NE Premium Assay - Product Description
ProteaseTag - COPD - Product Status
ProteaseTag - COPD - Product Description
ProteaseTag - Cystic Fibrosis - Product Status
ProteaseTag - Cystic Fibrosis - Product Description
ProteaseTag Active Immuno Assay - Chronic Human Diseases - Product Status
ProteaseTag Active Immuno Assay - Chronic Human Diseases - Product Description
ProteaseTag Active Immunoassay - Pancreatic Elastase - Product Status
ProteaseTag Active Immunoassay - Pancreatic Elastase - Product Description
ProteaseTag Active Immunoassay - Tryptase - Product Status
ProteaseTag Active Immunoassay - Tryptase - Product Description
Remote Respiratory Monitoring Tool - Product Status
Remote Respiratory Monitoring Tool - Product Description
SARS-CoV-2 Serology ELISA - Product Status
SARS-CoV-2 Serology ELISA - Product Description
ProAxsis Ltd, Key Employees
ProAxsis Ltd, Subsidiaries
Glossary

List of Figures

ProAxsis Ltd Pipeline Products by Equipment Type
ProAxsis Ltd Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Varian Medical Systems UK Ltd.
A J Cope & Son Ltd
Grifols UK Ltd
Biometrics Ltd